Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a ful l
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03158038”
into the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D2560C00014” into the search box, and click “Find a Study”.
The full title of your study is: A Phase 4, Randomized, Double-blind,
Placebo-controlled Study to Evaluate the Safety of 1 New 6:2 Influenza Virus
Reassortant in Adults
MedImmune Protocol number: D2560C00014
MedImmune, LLC, a member of the AstraZeneca Group, sponsored this study and
has its headquarters at One MedImmune Way, Gaithersburg, MD 20878 USA.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part i n
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about
clinical research participation. CISCRP is not involved
in recruiting patients for clinical studies, nor is it
involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 510
Boston, MA 02109
1-877-MED-HERO
www.ciscrp.org
8
Version: V2.3 11/2018